Access and Care Coverage
Access and Care Coverage Overview
The Access and Care Coverage category has the second-highest average score at 70.9/100 and the second smallest score range at 40 points. Denmark (84), the UK, Ireland, Norway, and Czechia emerge as the top scorers in this category, while China (43), Latvia, Belgium, Poland, and Japan had the lowest scores. Countries generally demonstrate that health systems offer access to and coverage for a wide range of drugs as well as diagnostic and treatment services for COPD. However, indicators specific to drug, treatment, and diagnostics access provide only broad insights into the standard co-payment and reimbursement policies in each country and do not reflect other factors that may impact access such as individual disability, mis- and underdiagnosis, and fluctuations in the availability of pharmaceuticals.
Access and Care Coverage Key Takeaways
The most important takeaways on Access and Care Coverage from the COPD index
Access and Care Coverage
Varying access to care: COPD care access and coverage varies significantly between countries, with a general need for better diagnostic conditions and stronger care referral pathways
Access and Care Coverage
Improved access to digital therapeutics and telemedicine needed: Greater use of telemedicine and digital care could improve general access to care, but also improve equity in terms of unmet care needs
Access and Care Coverage
Relatively good treatment access, but care not equaly accessible to everyone: significant part of population is facing inequity in access to care
Access and Care Coverage Indicators
Ranking across countries through different indicators of COPD Access and Care Coverage